Eurogenerics Eurogenerics
  • Home
  • About Us
    • Our Company
    • Activities
    • Certification
    • Work With Us
    • International Publication
  • Our Products
  • Our Services
  • Contact Us

Averkaz 4mg

Category: Montelukast Tag: Leukotriene Receptor Antagonist

Montelukast – Averkaz

4mg Chewable Tablet

DR-XY46081

OPEN MARKET

  • Description
  • Additional information

Description

MONTELUKAST is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor (CysLT1). The cysteinyl leukotrienes (LTc4, LTd4, LTE4) are products of arachidonic acid metabolism and are released from various cells, including mast cells and eosinophils. Cysteinyl leukotrienes and leukotriene receptor occupation have been correlated with pathophysiology of asthma, including airway edema, smooth muscle contraction, and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma.

Supplied in 4mg Chewable Tablet in Alu-Alu Blister pack of 10’s (Box of 30’s).

Additional information

Drug Type

ANTI-ASTHMA / COPD

Principal

The Acme Laboratories Ltd.

Registration Status

Registered

Related products

  • Averkaz 5

    Averkaz 5mg

    Montelukast
  • Averkaz 10

    Averkaz 10mg

    Montelukast

← View all products

  • Home
  • About Us
  • Our Products
  • Careers
  • Our Services
  • Contact Us
Euro Generics International Philippines © 2018